EVH WP12 organized its first workshop on the harmonisation of immunological assays across EVH laboratories
The European Vaccines Hub (EVH) Work Package (WP)12 held its first workshop on 27 February 2026 in Brussels, bringing together laboratory teams from across the EVH network and collabora [...]
EVH Regulatory Preparedness Strategy - Executive Summary
The European Vaccines Hub (EVH) serves as a coordinative platform for the development of pandemic vaccines and monoclonal antibodies (mAb). Its ambition is to support vaccine and antibody de [...]
EVH Working Group 1 on Pathogen Prioritization
As part of the European Vaccines Hub’s (EVH) broader scientific activities, work is progressing within the EVH Working Group 1 on Pathogen Prioritization (WG1). This Working Group complem [...]
EVH Working Group 2 on Pandemic Influenza
As part of its cross cutting scientific activities, the European Vaccines Hub (EVH) is carrying forward the work of its Working Group 2 on Pandemic Influenza (WG2). This initiative compleme [...]
Submission of the First EVH Multicentre Vaccine Trial
As part of Pillar 3 – Clinical Studies, the European Vaccines Hub (EVH) successfully achieved a major milestone in 2025 with the submission of its first multicentre Phase 4 vaccine trial [...]
1
© Copyright 2025 The European Vaccine Hub. All rights reserved
Designed and Developed by Pixwork